Partin AW - Search Results

1

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.

Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks JL, Park BH, Humphreys E, Partin AW, Han M, Netto GJ, Isaacs WB, De Marzo AM. Lotan TL, et al. Among authors: partin aw. Clin Cancer Res. 2011 Oct 15;17(20):6563-73. doi: 10.1158/1078-0432.CCR-11-1244. Epub 2011 Aug 30. Clin Cancer Res. 2011. PMID: 21878536 Free PMC article.

2

Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.

Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI. Partin AW, et al. Cancer. 1992 Jul 1;70(1):161-8. doi: 10.1002/1097-0142(19920701)70:1<161::aid-cncr2820700126>3.0.co;2-5. Cancer. 1992. PMID: 1606538

3

Prediction of prognosis in untreated stage A2 prostatic carcinoma.

Mohler JL, Partin AW, Epstein JI, Becker RL, Mikel UV, Sesterhenn IA, Mostofi FK, Gleason DF, Sharief Y, Coffey DS. Mohler JL, et al. Among authors: partin aw. Cancer. 1992 Jan 15;69(2):511-9. doi: 10.1002/1097-0142(19920115)69:2<511::aid-cncr2820690239>3.0.co;2-3. Cancer. 1992. PMID: 1728382

4

New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.

Isaacs WB, Isaacs JT, Kyprianou N, Burgers JK, Alexander RB, Partin AW, Mohler JL, Marshall FF, Coffey DS. Isaacs WB, et al. Among authors: partin aw. Eur Urol. 1990;18 Suppl 2:33-5. doi: 10.1159/000463958. Eur Urol. 1990. PMID: 2226604 Review. No abstract available.

5

Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage.

Christensen WN, Partin AW, Walsh PC, Epstein JI. Christensen WN, et al. Among authors: partin aw. Cancer. 1990 Feb 15;65(4):1021-7. doi: 10.1002/1097-0142(19900215)65:4<1021::aid-cncr2820650430>3.0.co;2-l. Cancer. 1990. PMID: 2404561 Review.

6

Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.

Mohler JL, Partin AW, Isaacs JT, Coffey DS. Mohler JL, et al. Among authors: partin aw. Cancer Res. 1988 Aug 1;48(15):4312-7. Cancer Res. 1988. PMID: 3390827

7

Time lapse videomicroscopic identification of Dunning R-3327 adenocarcinoma and normal rat prostate cells.

Mohler JL, Partin AW, Isaacs WB, Coffey DS. Mohler JL, et al. Among authors: partin aw. J Urol. 1987 Mar;137(3):544-7. doi: 10.1016/s0022-5347(17)44103-6. J Urol. 1987. PMID: 3820394

8

Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.

Partin AW, Getzenberg RH, CarMichael MJ, Vindivich D, Yoo J, Epstein JI, Coffey DS. Partin AW, et al. Cancer Res. 1993 Feb 15;53(4):744-6. Cancer Res. 1993. PMID: 7679049

9

Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells.

Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT. Rinker-Schaeffer CW, et al. Among authors: partin aw. Prostate. 1994 Nov;25(5):249-65. doi: 10.1002/pros.2990250505. Prostate. 1994. PMID: 7971516 Review.

10

Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.

Epner DE, Partin AW, Schalken JA, Isaacs JT, Coffey DS. Epner DE, et al. Among authors: partin aw. Cancer Res. 1993 May 1;53(9):1995-7. Cancer Res. 1993. PMID: 8481901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters